Microgen reports FY pre-tax profit
HIGHLIGHTS:
0
External
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.
Operating performance slightly ahead of market expectationsAdjusted operating margin* remains strong at 17.9%, ahead of the Board's stated target. All internal research and development costs are expensed as incurred with no capitalisation of development costs.Profit before tax from Continuing Operations of £4.2 million (2006: loss of £10.0 million)Revenue from Continuing Operations of £33.3 million (2006: £32.7 million)Microgen Aptitude gaining significant momentum and market recognitionStrong balance sheet with cash of £18.1 million (2006: £15.3 million)Fully diluted earnings per share 2.5p (2006: loss per share 10.3p). Adjusted diluted earnings per share 4.5p (2006: 3.0p)Proposed dividend increase of 33% with final dividend of 1.4p per share making a total of 2.0p for the year (2006: 1.5p) reflecting the confidence of the Board
Read the full statement here:Download the document now 158.9 kb (PDF File)